glutathione synthetase Inborn errors in the metabolism of | Orphanet Journal of Rare Diseases Glutathione Synthetase Antibody, PE, Novus

None of those checks and balances happen in the gray and black market

Copyright 2009-2026 All rights reserved

During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route

Most patients tolerate the treatment well

When prescribed and supervised by a licensed medical provider and sourced from a regulated US compounding pharmacy, peptide therapy has a strong safety profile